Results 251 to 260 of about 114,325,321 (319)

Properties of mouse alpha-galactosidase.

open access: yesBiochimica et biophysica acta, 1976
alpha-Galactosidase has been examined in various murine tissues using the substrate 4-methylumbelliferyl-alpha-galactoside. Mouse liver appears to contain a single major form of the enzyme, as judged by chromatography and electrophoresis. The enzmye was purified 467-fold with a yield of about 40% by a method involving chromatography on Concanavalin A ...
Lusis, A J, Paigen, K
core   +4 more sources
Some of the next articles are maybe not open access.

Related searches:

Is the alpha‐galactosidase A variant p.Asp313Tyr (p.D313Y) pathogenic for Fabry disease? A systematic review

Journal of Inherited Metabolic Disease, 2020
The identification of pathogenic GLA variants plays a central role in the establishment of a definite Fabry disease (FD) diagnosis. We aimed to review and interpret the published data on the p.Asp313Tyr (p.D313Y) variant pathogenicity and clinical ...
G. Effraimidis   +4 more
semanticscholar   +1 more source

Identification of a novel mutation in the alpha-galactosidase A gene in patients with Fabry disease

open access: yesClinical Biochemistry, 2012
OBJECTIVES: Mutation analysis of the alpha-galactosidase A (GLA) gene is a valuable tool for the diagnosis of affected families. In our work, we analyze about one thousand samples per year from patients suspected of having Fabry disease (FD).
Antonino Tuttolomondo   +2 more
exaly   +1 more source

Fabry's Disease: Alpha-Galactosidase Deficiency

Science, 1970
The leukocytes of male patients with Fabry's disease are deficient in α-galactosidase. The α-galactosidase activity in the leukocytes of female carriers of the disease is 15 to 40 percent of the amount present in normal leukocytes. The activities of β-galactosidase, β-acetylgalactosaminidase, and β-acetylglucosaminidase in the leukocytes of affected ...
openaire   +2 more sources

Pseudodeficiency of alpha-galactosidase A.

Clinical genetics, 1982
Apparent deficiency of alpha-galactosidase A was observed in a 51-year-old, clinically healthy male, with no clinical symptoms of Fabry disease, and without excess urinary excretion of ceramide trihexoside. The deficiency, which was similar to that found in Fabry disease patients, could be demonstrated using both synthetic and natural substrates.
G, Bach   +3 more
openaire   +1 more source

[Microbial alpha-galactosidase (a review)].

Prikladnaia biokhimiia i mikrobiologiia, 1982
The review discusses properties, distribution and potential use of microbial alpha-galactosidase (alpha-D-galactoside galactohydrolase, EC 3.2.1.22), the enzyme catalyzing degradation of alpha-D-galactoside bonds. Recent years have witnessed many publications describing microbial alpha-galactosidase which, in contrast to the similar enzyme from higher ...
I V, Ulezlo, O M, Zaprometova
openaire   +1 more source

Impact of lysosomal storage disorders on biology of mesenchymal stem cells: Evidences from in vitro silencing of glucocerebrosidase (GBA) and alpha‐galactosidase A (GLA) enzymes

Journal of Cellular Physiology, 2017
T. Squillaro   +8 more
semanticscholar   +1 more source

Molecular damage in Fabry disease: Characterization and prediction of alpha‐galactosidase A pathological mutations

Proteins: Structure, Function, and Bioinformatics, 2015
C. Riera   +6 more
semanticscholar   +1 more source

Alpha-Gal Syndrome: Involvement of Amblyomma americanum α-D-Galactosidase and β-1,4 Galactosyltransferase Enzymes in α-Gal Metabolism

Frontiers in Cellular and Infection Microbiology, 2021
Shahid Karim   +2 more
exaly  

Home - About - Disclaimer - Privacy